Peter von Czettritz

Practice Areas

Life sciences

Pharmaceutical Law

Healthcare advertising

Medicinal products

Medical Devices Law

Food Supplements

Competition Law

Publications

Latest Publications:

Germany: Drug & Medical Device Litigation 2025, Chapter 8, in ICLG (International Comparative Legal Guides) zusammen mit Tanja Strelow, Dr. Stephanie Thewes und Dr. Fabian Huber

Werbung für ein in der klinischen Studie befindliches Arzneimittel: § 3a HWG und § 21 Abs. 2 Nr. 2 AMG, in PharmR 1/2025, 18 zusammen mit Dr. Fabian Huber

Die Marktexklusivität der Orphan Drug VO – ein wettbewerbsrechtlich durchsetzbares Recht?, in PharmR 10/2024, 598 zusammen mit Dr. Fabian Huber

Das Herstellerprivileg nach Art. 5 Abs. 2 b der geänderten Verordnung (EG) 469/2009 über das ergänzende Schutzzertifikat für Arzneimittel, in PharmR 5/2024, 253 zusammen mit Dr. Stephanie Thewes

Germany: Drug & Medical Device Litigation 2024, Chapter 8, in ICLG (International Comparative Legal Guides) zusammen mit Tanja Strelow und Dr. Stephanie Thewes

Buchrezension: Produkthaftungshandbuch, Foerste/Graf von Westphalen, C.H. Beck Verlag, 4. Aufl. 2024, in PharmR 2024, 163

Die Bewerbung von Arzneimitteln und Medizinprodukten, § 7 Grundlagen und Strukturen, § 8 Das Heilmittelwerbegesetz, § 9 Das UWG im Heilmittelwerberecht in Meier/v. Czettritz/Gabriel/Kaufmann, Pharmarecht 3. Auflage, Beck Verlag 2023, zusammen mit Dr. Stephanie Thewes

Medizinprodukte, § 5 Entwicklung und Zertifizierung von Medizinprodukten, § 6 Inverkehrbringung und Überwachung von Medizinprodukten, in Meier/v. Czettritz/Gabriel/Kaufmann, Pharmarecht, 3. Auflage, Beck Verlag 2023, zusammen mit Tanja Strelow

Mitherausgeber des Lehrbuchs „Pharmarecht“ und gleichzeitig Autor von §§ 5-9 in Meier/v. Czettritz/Gabriel/Kaufmann, Pharmarecht, 3. vollständig überarbeitete Auflage, Beck Verlag 2023

„Off-Label bei Medizinprodukten“, MPR 2022, 89 ff. zusammen mit Dr. Christian Fulda

Erlass einer einstweiligen Verfügung in Patentsachen auch ohne Einspruchs- oder Nichtigkeitsverfahren möglich. Anmerkung zu EuGH-Urteil vom 28.04.2022, PharmR 2022, 497 ff.

Die BGH-Entscheidung „Werbung für Fernbehandlung“ vom 09.12.2021 sowie die Neuerungen des § 9 S. 2 HWG, PharmR 5/2022, 349 zusammen mit Dr. Stephanie Thewes

Career

Peter von Czettritz has been a partner at Preu Bohlig since 2007, where he specialises in advising on German and European pharmaceutical and medical devices law. He advises in particular on authorisation and certification procedures, third-party opposition proceedings and compliance issues in regulated industries. Previously, he was a partner at the law firm Harms & Melzer in Munich for almost 20 years.

He studied law and political science at the Ludwig-Maximilians-University of Munich and at the Université Aix-Marseille III. In addition to his work as a lawyer, he is the editor of two specialist journals, a lecturer at the Universities of Augsburg and Marburg and a member of several specialist committees. His work is regularly recognised by industry rankings and awards.

Professional Memberships

German Association for the Protection of Intellectual Property and Copyright (GRUR

Middle-European Society for Regulatory Affairs (MEGRA)

German Society for Regulatory Affairs (DGRA)

Personal

Peter von Czettritz is one of the central established names in German and European pharmaceutical law. He has been advising pharmaceutical and medical device companies on all aspects of pharmaceutical, medical device, patent and competition law for over three decades. In addition to traditional advice, his practice also includes representation in contentious and administrative proceedings - with particular experience in authorisation and certification procedures as well as in third-party opposition proceedings at national and European level. He also specialises in compliance advice and product liability issues, particularly in the regulated environment.

Peter von Czettritz is editor of the specialist journals PharmaRecht and MedizinProdukteRecht and author of numerous publications. He is a member of several key industry associations, including the BAH Legal Committee, the BPI Committee for Substance-Based Medical Devices and the BVMed Medical Devices Law Network. In 2001, he was honoured with the PharmaRechts-Preis for his scientific work.

He is a lecturer for Drug Regulatory Affairs at the University of Augsburg and for Pharmaceutical Law at the Philipps University of Marburg.

Clients

Companies in the pharmaceutical sector, in particular leading generics manufacturers.

Industry Sector Expertise

Regulatory procedures in pharmaceutical and medical device law

(authorisation and certification, third-party opposition proceedings, advice in the context of regulatory affairs)

Product liability and compliance in regulated industries

(liability issues for medicinal products and medical devices, internal processes, risk management)

Patent and competition law disputes in the pharmaceutical sector

(listing disputes, preliminary injunctions, SPC nullity actions, biosimilar market launches)

Advertising law disputes in the healthcare sector

(drug advertising law, advertising to healthcare professionals, official advertising bans)

Contract law and market-related issues in the supply of medicinal products

(discount agreements, drug price regulation, interaction with health insurance funds and associations)

Languages Spoken

German, English, French

Awards